Cromatest

378 results

  • Glucose MR 2x30 ml

    In the Trinder reaction, glucose is oxidised to D-gluconate by glucose oxidase (GOD), with formation of hydrogen peroxide. In the presence of peroxidase (POD), phenol and 4-aminoantipyrine (4-AA) are condensed by hydrogen peroxide, forming a red quinoneimine proportional to the concentration of glucose in the sample.

  • Glucose MR 8x30 ml

    In the Trinder reaction, glucose is oxidised to D-gluconate by glucose oxidase (GOD), with formation of hydrogen peroxide. In the presence of peroxidase (POD), phenol and 4-aminoantipyrine (4-AA) are condensed by hydrogen peroxide, forming a red quinoneimine proportional to the concentration of glucose in the sample.

  • Glucose MR 18x30 ml

    In the Trinder reaction, glucose is oxidised to D-gluconate by glucose oxidase (GOD), with formation of hydrogen peroxide. In the presence of peroxidase (POD), phenol and 4-aminoantipyrine (4-AA) are condensed by hydrogen peroxide, forming a red quinoneimine proportional to the concentration of glucose in the sample.

  • Glucose MR 2x40 ml

    In the Trinder reaction, glucose is oxidised to D-gluconate by glucose oxidase (GOD), with formation of hydrogen peroxide. In the presence of peroxidase (POD), phenol and 4-aminoantipyrine (4-AA) are condensed by hydrogen peroxide, forming a red quinoneimine proportional to the concentration of glucose in the sample.

  • GOT/GPT Color 2x100ml

    This technique employs a separation method based on the selective precipitation of apoprotein-B-containing lipoproteins (VLDL, LDL and (a)Lpa) by the action of phosphotungstic acid/Cl2Mg, sedimentation of the precipitate by centrifugation and subsequent enzymatic analysis as residual cholesterol from the high-density lipoproteins (HDL) contained in the clear supernatant.

  • HDL-Cholesterol 2x40 ml

    Hydrogen peroxide derived from the oxidase reaction is quantified by a Trinder-type reaction in which the chromogenic derivative HTIB and 4-aminoantipyrine (4-AA) condense in the presence of peroxidase (POD) to form a red quinonimine dye.

  • HDL-Cholesterol Direct 40ml

    This technique employs a separation method based on the selective precipitation of apoprotein-B-containing lipoproteins (VLDL, LDL and (a)Lpa) by the action of phosphotungstic acid/Cl2Mg, sedimentation of the precipitate by centrifugation and subsequent enzymatic analysis as residual cholesterol from the high-density lipoproteins (HDL) contained in the clear supernatant.

  • HDL-Cholesterol Direct 320 ml

    This technique employs a separation method based on the selective precipitation of apoprotein-B-containing lipoproteins (VLDL, LDL and (a)Lpa) by the action of phosphotungstic acid/Cl2Mg, sedimentation of the precipitate by centrifugation and subsequent enzymatic analysis as residual cholesterol from the high-density lipoproteins (HDL) contained in the clear supernatant.

  • Creatine Kinase BR 1x40 ml

    Creatine kinase (CK) catalyzes the reaction between creatine phosphate (CP) and adenosine 5'-diphosphate (ADP), forming creatine and adenosine 5'-triphosphate (ATP). The latter converts glucose to glucose-6-phosphate (G6P) in the presence of hexokinase (HK). G6P is oxidized to gluconate-6P in the presence of reduced nicotinamide adenine dinucleotide phosphate (NADP), catalyzed by glucose-6-phosphate dehydrogenase (G6PDH). The conversion is kinetically monitored at 340 nm through the increase in absorbance resulting from the reduction of NADP to NADPH, proportional to CK activity in the sample. The inclusion of N-acetylcysteine (NAC) in this method allows optimal enzyme activation.

  • Creatine Kinase BR 5x40 ml

    Creatine kinase (CK) catalyzes the reaction between creatine phosphate (CP) and adenosine 5'-diphosphate (ADP), forming creatine and adenosine 5'-triphosphate (ATP). The latter converts glucose to glucose-6-phosphate (G6P) in the presence of hexokinase (HK). G6P is oxidized to gluconate-6P in the presence of reduced nicotinamide adenine dinucleotide phosphate (NADP), catalyzed by glucose-6-phosphate dehydrogenase (G6PDH). The conversion is kinetically monitored at 340 nm through the increase in absorbance resulting from the reduction of NADP to NADPH, proportional to CK activity in the sample. The inclusion of N-acetylcysteine (NAC) in this method allows optimal enzyme activation.

  • Creatine Kinase BR 1x50 ml

    Creatine kinase (CK) catalyzes the reaction between creatine phosphate (CP) and adenosine 5'-diphosphate (ADP), forming creatine and adenosine 5'-triphosphate (ATP). The latter converts glucose to glucose-6-phosphate (G6P) in the presence of hexokinase (HK). G6P is oxidized to gluconate-6P in the presence of reduced nicotinamide adenine dinucleotide phosphate (NADP), catalyzed by glucose-6-phosphate dehydrogenase (G6PDH). The conversion is kinetically monitored at 340 nm through the increase in absorbance resulting from the reduction of NADP to NADPH, proportional to CK activity in the sample. The inclusion of N-acetylcysteine (NAC) in this method allows optimal enzyme activation.

  • Creatine Kinase MR 1x40 ml

    The higher activity of CK in normal sera is due to the isoenzymes CK-MM and CK-MB present in muscle and cardiac tissues. CK-BB is usually present at very low concentrations. Both creatine kinase (CK) enzymes are dimers formed by the association of two muscle (M) and brain (B) subunits. Immunoinhibition with a specific antibody for both MM subunits and the individual unit of CK-MB allows the determination of the B subunit. The activity corresponding to half of CK-MB is measured through the increase in absorbance resulting from coupled reactions.